Rivastigmine for dementia associated with Parkinson's disease.
Harada
Caroline N
CN
Shega
Joseph W
JW
Sachs
Greg A
GA
D015982:Bias; D002800:Cholinesterase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use*; D003627:Data Interpretation, Statistical; D003704:Dementia / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D009325:Nausea / Q000139:chemically induced; D010300:Parkinson Disease / Q000150:complications*; D048448:Phenylcarbamates / Q000009:adverse effects / Q000627:therapeutic use*; D000068836:Rivastigmine; D014202:Tremor / Q000139:chemically induced; D014839:Vomiting / Q000139:chemically induced
D002800:Cholinesterase Inhibitors; D048448:Phenylcarbamates; D000068836:Rivastigmine